The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Results of a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates.
Daniel D. Von Hoff
Consultant or Advisory Role - Celgene (U)
Honoraria - Celgene
Research Funding - Celgene
Thomas J. Ervin
Research Funding - Celgene
Francis P. Arena
Research Funding - Celgene
E. Gabriela Chiorean
Research Funding - Celgene
Jeffrey R. Infante
No relevant relationships to disclose
Malcolm J. Moore
Consultant or Advisory Role - Celgene
Research Funding - Celgene
Thomas E. Seay
Research Funding - Celgene
Sergei Tjulandin
Research Funding - Celgene
Wen Wee Ma
Research Funding - Celgene
Mansoor N. Saleh
Research Funding - Celgene
Marion Harris
No relevant relationships to disclose
Michele Reni
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Ramesh K. Ramanathan
Consultant or Advisory Role - Celgene (U)
Honoraria - Abraxis BioScience
Research Funding - Celgene
Josep Tabernero
Consultant or Advisory Role - Celgene
Manuel Hidalgo
Consultant or Advisory Role - Celgene
Honoraria - Celgene
Research Funding - Celgene
Eric Van Cutsem
Research Funding - Celgene
David Goldstein
Consultant or Advisory Role - Celgene (U)
Research Funding - Celgene
Xinyu Wei
Employment or Leadership Position - Celgene
Stock Ownership - Celgene
Jose Luis Iglesias
Employment or Leadership Position - Bionomics
Stock Ownership - Celgene
Markus Frederic Renschler
Employment or Leadership Position - Celgene
Stock Ownership - Celgene (I)